ArticleBioengineered2022

Diosgenin reduces phosphodiesterase 3B (PDE3B) through AMP-activated protein kinase/ mechanistic target of rapamycin (AMPK/mTOR) signaling pathway to ameliorate streptozotocin-induced pancreatic β-cell apoptosis and dysfunction.

Lijie Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.